NAMI vs ZYBT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

NAMI

35.4
AI Score
VS
ZYBT Wins

ZYBT

36.9
AI Score

Investment Advisor Scores

NAMI

35score
Recommendation
AVOID NEW MONEY

ZYBT

37score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric NAMI ZYBT Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -31.9% -40.9% NAMI
Earnings Growth 0.0% -79.6% NAMI
Tradestie Score 35.4/100 36.9/100 ZYBT
Profit Margin -23.9% -60.0% NAMI
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

NAMI 1M: -6.6% · 3M: -42.5% ZYBT 1M: +5.8% · 3M: -49.1%

Current Technical Phase

NAMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -15.7%), weak momentum, RSI 42

RSI (14): 42.3 · Price: $1.85

ZYBT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 52

RSI (14): 51.6 · Price: $1.45

Fundamentals Snapshot

Metric NAMI ZYBT
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E 0.9 —
Revenue (TTM) — —
Revenue Growth -0.3% -0.4%
Gross Margin 0.1% 0.2%
Operating Margin -0.1% -0.8%
EPS 1.93 -0.20
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZYBT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.